Suvretta Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30M | Buy |
3,688,858
+1,127,954
| +44% | +$9.18M | 0.91% | 32 |
|
|
2025
Q1 | $20.1M | Buy |
2,560,904
+1,984,748
| +344% | +$15.6M | 0.75% | 36 |
|
|
2024
Q4 | $8.58M | Sell |
576,156
-87,447
| -13% | -$1.3M | 0.29% | 55 |
|
|
2024
Q3 | $10.1M | Sell |
663,603
-293,701
| -31% | -$4.49M | 0.32% | 50 |
|
|
2024
Q2 | $14.6M | Hold |
957,304
| – | – | 0.54% | 44 |
|
|
2024
Q1 | $18.1M | Hold |
957,304
| – | – | 0.67% | 40 |
|
|
2023
Q4 | $18.3M | Buy |
957,304
+360,205
| +60% | +$6.88M | 0.83% | 37 |
|
|
2023
Q3 | $10.7M | Buy |
+597,099
| New | +$10.7M | 0.58% | 44 |
|